Asia accounted for approximately 45% of the global breast cancer cases in 2020, with Mainland China, India, and Japan contributing the majority of cases.
Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…
Hong Kong - Novotech, the leading Asia P
Read more